Français
ItalianoBond Pfizer 3.2% ( US717081EN91 ) in USD
| Issuer | Pfizer | ||||||
| Market price | 99.81 % ▼ | ||||||
| Country |  United States
|
||||||
| ISIN code |
 US717081EN91 ( in USD )
|
||||||
| Interest rate | 3.2% per year ( payment 2 times a year) | ||||||
| Maturity | 15/09/2023 - Bond has expired | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 1 000 000 000 USD | ||||||
| Cusip | 717081EN9 | ||||||
| Standard & Poor's ( S&P ) rating | NR | ||||||
| Moody's rating | NR | ||||||
| Detailed description |
Pfizer is a multinational pharmaceutical and biotechnology company headquartered in New York City that researches, develops, manufactures, and markets drugs and vaccines globally. The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US717081EN91, pays a coupon of 3.2% per year. The coupons are paid 2 times per year and the Bond maturity is 15/09/2023 The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US717081EN91, was rated NR by Moody's credit rating agency. The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US717081EN91, was rated NR by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||